Search results for "immunomodulation"

showing 10 items of 118 documents

Homeostasis of Microglia in the Adult Brain: Review of Novel Microglia Depletion Systems.

2015

Microglia are brain macrophages that emerge from early erythro-myeloid precursors in the embryonic yolk sac and migrate to the brain mesenchyme before the blood brain barrier is formed. They seed the brain, and proliferate until they have formed a grid-like distribution in the central nervous system that is maintained throughout lifespan. The mechanisms through which these embryonic-derived cells contribute to microglia homoeostasis at steady state and upon inflammation are still not entirely clear. Here we review recent studies that provided insight into the contribution of embryonically-derived microglia and of adult 'microglia-like' cells derived from monocytes during inflammation. We ex…

NeuroimmunomodulationCellular differentiationMesenchymeImmunologyCentral nervous systemEmbryonic DevelopmentInflammation610 Medicine & healthBiologyBlood–brain barrier10263 Institute of Experimental ImmunologymedicineImmunology and AllergyAnimalsHomeostasisHumansNeuroinflammationInflammation2403 ImmunologyMicrogliaMacrophagesBrainCell DifferentiationEmbryonic stem cellDisease Models Animalmedicine.anatomical_structureImmunologyModels Animal2723 Immunology and Allergy570 Life sciences; biologyMicrogliamedicine.symptomTrends in immunology
researchProduct

Immunomodulatory Therapy Does Not Increase the Risk of Cancer in Persons With Inflammatory Bowel Disease and a History of Extracolonic Cancers.

2019

Immunosuppressant therapies (IMTs; thiopurines, anti-tumor necrosis factor agents) may influence the immunologic control of cancer and might facilitate the spread and recurrence of cancer. This study assesses the impact of the use of IMTs on the development of incident cancers (recurrent or new) in patients with inflammatory bowel disease (IBD) and a history of malignancy.Patients with IBD included in the ENEIDA registry with a history of cancer without being exposed to IMTs were identified and retrospectively reviewed and compared regarding further treatment with IMTs or not by means of a log-rank test.Overall, 520 patients with previous extracolonic cancer naive to IMTs before the diagnos…

OncologyMalemedicine.medical_specialtyInflammatory bowel diseaseRisk AssessmentTime-to-TreatmentImmunomodulation03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineNeoplasmsmedicineHumanscardiovascular diseasesRegistriesHepatologybusiness.industryIncidence (epidemiology)IncidenceGastroenterologyCancerMiddle Agedmedicine.diseaseInflammatory Bowel DiseasesOutcome and Process Assessment Health CareSpain030220 oncology & carcinogenesiscardiovascular system030211 gastroenterology & hepatologyFemaleRisk assessmentbusinessImmunosuppressive AgentsThe American journal of gastroenterology
researchProduct

Mesenchymal Stem Cells in Solid Organ Transplantation (MiSOT) Fourth Meeting

2013

The Fourth Expert Meeting of the Mesenchymal Stem Cells in Solid Organ Transplantation (MiSOT) Consortium took place in Barcelona on October 19 and 20, 2012. This meeting focused on the translation of preclinical data into early clinical settings. This position paper highlights the main topics explored on the safety and efficacy of mesenchymal stem cells as a therapeutic agent in solid organ transplantation and emphasizes the issues (proper timing, concomitant immunossupression, source and immunogenicity of mesenchymal stem cells, and oncogenicity) that have been addressed and will be followed up by the MiSOT Consortium in future studies.

Oncologymedicine.medical_specialtyTransplantationFuture studiesbusiness.industryMesenchymal stem cellClinical settingsPreclinical dataClinical trialTransplantationImmunomodulationInternal medicineImmunologymedicinePosition paperMesenchymal stem cellsPosition paperSolid organ transplantationbusinessTransplantation
researchProduct

Osteonecrosis of the jaw in the era of targeted therapy and immunotherapy in oncology

2019

Osteonecrosis of the jaw (ONJ) is a well-known pathological condition in oncology derived from the use of bisphosphonates (BPs) and denosumab. Many molecular and immunological targets have been introduced for daily use in cancer treatment in recent years; consequently, new cases of ONJ have been reported in association with these drugs, especially if administered with BPs and denosumab. When the drugs are administered alone, ONJ is rarely seen. The objective of our study was to analyze the recent literature relative to the association of ONJ with these new drugs highlighting the pathogenic, clinical and therapeutic aspects. The close collaboration between maxillofacial surgeon, oncologist, …

Oncologymedicine.medical_specialtymedicine.medical_treatmentOdontologíaReview ArticleMaxilaresTargeted therapyOncologíaImmunomodulation03 medical and health sciences0302 clinical medicineInternal medicinemedicineOral manifestations030223 otorhinolaryngologyBonePathologicalbusiness.industryGénéralités030206 dentistryImmunotherapyCáncermedicine.diseaseCancer treatmentDenosumabSurgeryOral SurgeryOsteonecrosis of the jawbusinessAngiogenesis modulatorsInfectionmedicine.drug
researchProduct

Effect of Extra Virgin Olive Oil and Table Olives on the ImmuneInflammatory Responses: Potential Clinical Applications

2017

Background and Objective: Extra virgin olive oil (EVOO) is the common element among the Mediterranean countries. It can be considered a nutraceutical and functional food, thanks to its bioactive compounds. It can act and modulate different processes linked to ageing and age-related diseases related to a common chronic low grade inflammation. Depending on the cultivar, the growth conditions, the period of harvesting, the productive process and time of product storage, EVOO could contain different amount of vegetal components. Of course, the same is for table olives. Methods: The aim of our review is to summarize the effects of EVOO and table olives on the immunemediated inflammatory respons…

Polyphenol0301 basic medicineMediterranean dietTable oliveEndocrinology Diabetes and MetabolismContext (language use)Diet MediterraneanAntioxidantsneuroinflammationImmunomodulation03 medical and health sciencesNutraceuticalFunctional foodFunctional FoodOleaFood PreservedFood QualityAnimalsHumansImmunology and AllergyFood scienceOlive OilSettore MED/04 - Patologia GeneraleEvidence-Based Medicine030109 nutrition & dieteticsbiologyAnti-Inflammatory Agents Non-SteroidalEVOOmediterranean dietDietary patternbiology.organism_classificationImmune System Diseasestable olivesOleaFruitDietary SupplementsNutraceuticalFood qualityOlive oilEndocrine, Metabolic & Immune Disorders - Drug Targets
researchProduct

Human Amnion-Derived Mesenchymal Stromal Cells: A New Potential Treatment for Carbapenem-Resistant Enterobacterales in Decompensated Cirrhosis

2022

Background: Spontaneous bacterial peritonitis (SBP) is a severe and often fatal infection in patients with decompensated cirrhosis and ascites. The only cure for SBP is antibiotic therapy, but the emerging problem of bacterial resistance requires novel therapeutic strategies. Human amniotic mesenchymal stromal cells (hA-MSCs) possess immunomodulatory and anti-inflammatory properties that can be harnessed as a therapy in such a context. Methods: An in vitro applications of hA-MSCs in ascitic fluid (AF) of cirrhotic patients, subsequently infected with carbapenem-resistant Enterobacterales, was performed. We evaluated the effects of hA-MSCs on bacterial load, innate immunity factors, and macr…

QH301-705.5Placentacirrhosis; ascitic fluid; spontaneous bacterial peritonitis; human amnion-derived mesenchymal stromal cells; carbapenem-resistant Enterobacterales; pattern recognition molecules; ficolins; complement; placentaComplementEnterobacterPeritonitisMesenchymal Stem Cell Transplantationbeta-Lactam ResistanceCatalysisImmunomodulationInorganic ChemistryPhagocytosisSpontaneous bacterial peritonitisHumansHuman amnion-derived mesenchymal stromal cellsAmnionBiology (General)Physical and Theoretical ChemistryQD1-999Complement ActivationMolecular BiologySpectroscopyAscitic fluidMacrophagesCarbapenem-resistant EnterobacteralesOrganic ChemistryPattern recognition moleculesEnterobacteriaceae InfectionsMesenchymal Stem CellsPeritoneal FibrosisFicolinsComplement System ProteinsGeneral MedicineBacterial LoadComputer Science ApplicationsChemistryTreatment OutcomeCirrhosisCarbapenemsReceptors Pattern RecognitionDisease SusceptibilityInflammation MediatorsBiomarkersInternational Journal of Molecular Sciences; Volume 23; Issue 2; Pages: 857
researchProduct

Lentiviral transduction of face and limb flaps: implications for immunomodulation of vascularized composite allografts.

2012

Background Ex vivo introduction of an immunomodulatory transgene into a face or hand allograft may improve the risk-to-benefit ratio of vascularized composite allografts. Abrogation of the immunogenicity of the skin component of a face or hand allograft may decrease alloreactivity and permit the induction of immunologic tolerance. Proof-of-principle demonstrations of transduction of composite tissue have been established using adenoviral vectors, producing transient gene expression. The authors hypothesized that transduction, integration, and long-term expression of transgenes in a vascularized composite allograft could be achieved using lentiviral vectors. Methods Ex vivo transduction of h…

Reporter genePathologymedicine.medical_specialtybusiness.industryTransgeneLentivirusGene Transfer TechniquesExtremitiesTransfectionCell sortingSurgical FlapsViral vectorRatsImmunomodulationTransduction (genetics)Transduction GeneticFaceCancer researchMedicineAnimalsHumansSurgeryIntradermal injectionbusinessEx vivoPlastic and reconstructive surgery
researchProduct

Flavonoids against the SARS-CoV-2 induced inflammatory storm

2021

The disease severity of COVID-19, especially in the elderly and patients with co-morbidities, is characterized by hypercytokinemia, an exaggerated immune response associated with an uncontrolled and excessive release of proinflammatory cytokine mediators (cytokine storm). Flavonoids, important secondary metabolites of plants, have long been studied as therapeutic interventions in inflammatory diseases due to their cytokine-modulatory effects. In this review, we discuss the potential role of flavonoids in the modulation of signaling pathways that are crucial for COVID-19 disease, particularly those related to inflammation and immunity. The immunomodulatory ability of flavonoids, carried out …

Settore BIO/17 - Istologia0301 basic medicinePhytochemicalsAnti-Inflammatory AgentsAnti-inflammatory effectsInflammationRM1-950ReviewCytokine stormProinflammatory cytokineImmunomodulationEndothelial activation03 medical and health sciences0302 clinical medicineImmune systemAnimalsHumansMedicineDipeptidyl peptidase-4InflammationFlavonoidsPharmacologySARS-CoV-2business.industryfungiCOVID-19food and beveragesInflammasomeGeneral Medicinemedicine.diseaseCOVID-19 Drug Treatment3. Good health030104 developmental biology030220 oncology & carcinogenesisImmunologyTherapeutics. Pharmacologymedicine.symptomSignal transductionCytokine Release SyndromebusinessCytokine stormmedicine.drugBiomedicine & Pharmacotherapy
researchProduct

Mesenchymal Stromal cells from Wharton's jelly (MSCs): coupling their hidden differentiative program to their frank immunomodulatory phenotype.

2018

No abstract

Settore BIO/17 - IstologiaWharton's jelly mesenchymal stromal cells differentiation immunomodulation umbilical cord stem cells
researchProduct

The value of Phosphohistone H3 as a cell proliferation marker in oral squamous cell carcinoma. A comparative study with Ki-67 and the mitotic activit…

2022

The Phosphohistone H3 (PHH3) antibody is recognized as a biomarker of cell proliferation, specific for cells in mitosis, of prognostic value in different malignant neoplasms, however it has been poorly studied in oral squamous cell carcinoma (OSCC). The main objective of this study was to evaluate the immunoexpression of the PHH3 in the OSCC, through the correlation with the immunoexpression of Ki-67, the mitotic activity index (MAI), histological grading, clinical-morphological parameters and the rate of survival. The study sample consisted of 62 cases of OSCC diagnosed in the Pathological Anatomy Laboratory of the Faculty of Dentistry, University of the Republic (Uruguay). In each of them…

Squamous Cell Carcinoma of Head and NeckimmunomodulationPrognosisImmunohistochemistryHistonesKi-67 AntigenOtorhinolaryngologyerythromycininflammationHead and Neck NeoplasmsBiomarkers TumorCarcinoma Squamous Celloxidative stressHumansMouth NeoplasmsSurgeryPhosphorylationGeneral DentistryUNESCO:CIENCIAS MÉDICASoral mucositisCell ProliferationMedicina Oral Patología Oral y Cirugia Bucal
researchProduct